COMPANY

StemMed

Keywords: oncology

Profile checked Oct 10, 2026

NIH awards 4

Annual award amounts. Total $801K.

Apr 14, 2017 NIH award 4R42DK104494-02 FY2017: $169,159 awarded for that fiscal year; activity R42 (STTR); PI TWEARDY, DAVID JOHN; recipient as written: STEMMED, LTD, HOUSTON, TX. Oral Small Molecule STAT3 Inhibitor to Treat Cach source ↗
Apr 7, 2016 NIH award 1R42DK104494-01A1 FY2016: $215,557 awarded for that fiscal year; activity R42 (STTR); PI TWEARDY, DAVID JOHN; recipient as written: STEMMED, LTD, HOUSTON, TX. Oral Small Molecule STAT3 Inhibitor to Treat Ca source ↗
Sep 20, 2013 NIH award 3R41CA153658-01A1S1 FY2013: $139,030 awarded for that fiscal year; activity R41 (STTR); PI TWEARDY, DAVID JOHN; recipient as written: STEMMED, LTD, HOUSTON, TX. Chemical probes that target Stat3 to treat ca source ↗
Sep 26, 2012 NIH award 1R41CA153658-01A1 FY2012: $277,365 awarded for that fiscal year; activity R41 (STTR); PI TWEARDY, DAVID JOHN; recipient as written: STEMMED, LTD, HOUSTON, TX. Chemical probes that target Stat3 to treat canc source ↗